NEW YORK, March 1, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Horizon Pharma plc ("Horizon" or "the Company") (NASDAQ: HZNP). Such investors are advised to contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz at firstname.lastname@example.org or 212-697-6484.
This investigation concerns whether Horizon and certain of its officers and/or directors have violated the Federal Securities Laws under the Securities Exchange Act of 1934 (the "Exchange Act").
On February 29, 2016, Horizon released its 2015 annual report and included that the company received a subpoena in November 2015 from the U.S. attorney's office for the Southern District of New York requesting documents and information related to the Horizon's patient assistance programs, which include offering free medications and copay tickets to help cover out-of-pocket drug costs, and other aspects of Horizon's sales and marketing activities.
Following this news, Horizon stock fell $2.63, or 13.3%, to close at $17.16 per share on February 29, 2016.
If you are aware of any facts relating to this investigation, or purchased shares of Horizon, you can assist this investigation by visiting the firm's website: http://www.bgandg.com/#!hznp/ygzdg. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email email@example.com. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | firstname.lastname@example.org
SOURCE Bronstein, Gewirtz & Grossman, LLC